SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/EA30FFE332E4DF861DCC466A8F349F74C8AC9B54DF217AA84EDDE675022C8CBF59770CDE28A357C1FD947966C4BB1511>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/EA30FFE332E4DF861DCC466A8F349F74C8AC9B54DF217AA84EDDE675022C8CBF59770CDE28A357C1FD947966C4BB1511
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/EA30FFE332E4DF861DCC466A8F349F74C8AC9B54DF217AA84EDDE675022C8CBF59770CDE28A357C1FD947966C4BB1511
http://www.w3.org/2000/01/rdf-schema#comment
"Tumor marker mASH1 was highly (sensitivity of 71%) and specifically (specificity of 95%) expressed in poorly differentiated neuroendocrine carcinoma."
xsd:string
http://purl.uniprot.org/uniprot/#_34F1CB32B2E3E57E9535B954412385FDE0E6414499DE2BB27835F228CD943250EDC03595CB5865DB720B6445827358A0
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/EA30FFE332E4DF861DCC466A8F349F74C8AC9B54DF217AA84EDDE675022C8CBF59770CDE28A357C1FD947966C4BB1511
http://purl.uniprot.org/uniprot/P50553
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EA30FFE332E4DF861DCC466A8F349F74C8AC9B54DF217AA84EDDE675022C8CBF59770CDE28A357C1FD947966C4BB1511
http://purl.uniprot.org/uniprot/#_P50553-mappedCitation-18587321
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EA30FFE332E4DF861DCC466A8F349F74C8AC9B54DF217AA84EDDE675022C8CBF59770CDE28A357C1FD947966C4BB1511